Have a personal or library account? Click to login
Comparing triggers and comorbidities of acute exacerbations in COPD: Smokers versus non-smokers Cover

Comparing triggers and comorbidities of acute exacerbations in COPD: Smokers versus non-smokers

Open Access
|Jul 2025

References

  1. WHO. Chronic obstructive pulmonary disease (COPD). 2023 [ cited 2024 May 31]. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
  2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Plos Medicine. 2006;3(11): e442. doi:10.1371/journal.pmed.0030442
  3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2019 Report. 2019.
  4. Müllerová H, Shukla A, Hawkins A, Quint J. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open. 2014;4(12): e006171. doi:10.1136/bmjopen-2014-006171
  5. Montserrat-Capdevila J, Godoy P, Marsal JR, Barbé F, Galván L. Risk factors for exacerbation in chronic obstructive pulmonary disease: a prospective study. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease. 2016;20(3): 389–395. doi:10.5588/ijtld.15.0441
  6. Brashier BB, Kodgule R. Risk factors and pathophysiology of chronic obstructive pulmonary disease (COPD). The Journal of the Association of Physicians of India. 2012;60(Suppl): 17–21.
  7. Zeng G, Sun B, Zhong N. Non-smoking-related chronic obstructive pulmonary disease: a neglected entity? Respirology (Carlton, Vic.). 2012;17(6): 908–912. doi:10.1111/j.1440-1843.2012.02152.x
  8. Mathew N, Xavier Z, Deshmukh AS, Deshmukh H, Jadhav S, Kasat S. The study of aetiology of chronic obstructive pulmonary disease (COPD) in non-smokers. Journal of Pulmonary & Respiratory Medicine. 2015;5: 1–3. doi:10.4172/2161-105X.1000304
  9. Mahmood T, Singh RK, Kant S, Shukla AD, Chandra A, Srivastava RK. Prevalence and etiological profile of chronic obstructive pulmonary disease in non-smokers. Lung India: Official Organ of Indian Chest Society. 2017;34: 122–126. doi:10.4103/0970-2113.201298
  10. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2017 Report. 2017 [cited 2024 May 31]. Available from: http://goldcopd.org
  11. Centers for Disease Control and Prevention (CDC). National Health Interview Survey, 2015: Public use data file documentation. U.S. Department of Health and Human Services; 2015 [cited 2024 May 31]. Available from: https://www.cdc.gov/nchs/nhis.htm
  12. World Health Organization (WHO). WHO global report on trends in tobacco smoking 2000–2025. World Health Organization; 2016 [cited 2024 May 31]. Available from: https://www.who.int/publications/i/item/9789241514170
  13. Ehrlich RI, White N, Norman R, Laubscher R, Steyn K, Lombard C, et al. Predictors of chronic bronchitis in South African adults. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease. 2004;8: 369–376.
  14. Brashier B, Gangavane S, Valsa S, Gaikwad SN, Ghorpade SV, Mandrekar S, Salvi, S. Almost half the patients treated for pulmonary tuberculosis (TB) show evidence of obstructive airways disease (OAD). In: European Respiratory Society Annual Congress, 15 September 2007 was held at Stockholm, Sweden, p.15–19.
  15. Crisafulli E, Guerrero M, Ielpo A, Ceccato A, Huerta A, Gabarrús A, et al. Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a propensity matched analysis. Scientific Reports. 2018;8(1): 9236. doi:10.1038/s41598-018-27680-y
  16. Sinha T, Nalli SK, Toppo A. A study of clinical profile of patients with chronic obstructive pulmonary disease. International Journal of Community Medicine and Public Health. 2017;4: 1000–1004. doi:10.18203/2394-6040.ijcmph20171314
  17. Baneen U, Naseem S. Correlation of severity of chronic obstructive pulmonary disease with serum vitamin D level. Journal of Family Medicine and Primary Care. 2019;8(7): 2268–2277. doi:10.4103/jfmpc.jfmpc_404_19
  18. Bajpai J, Kant S, Bajaj DK, Pradhan A, Srivastava K, Pandey AK. Clinical, demographic and radiological profile of smoker COPD versus nonsmoker COPD patients at a tertiary care center in North India. Journal of Family Medicine and Primary Care. 2019;8(7): 2364–2368. doi:10.4103/jfmpc.jfmpc_347_19
  19. Sijapati M, Bhatta N, Khanal B, Lamsal M, Chaudhary S. Study of factors determining outcome in the hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). Journal of Universal College of Medical Sciences. 2014;2(2): 28–34. doi:10.3126/jucms.v2i2.11171
  20. Zhang J, Lin XF, Bai CX. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study. International Journal of Chronic Obstructive Pulmonary Disease. 2014;9: 57. doi:10.2147/COPD.S52416
  21. Mohapatra PR, Janmeja AK. Factors associated with hospital admission in patients with acute exacerbation of chronic obstructive pulmonary disease. The Indian Journal of Chest Diseases & Allied Sciences. 2010;52(4): 203–206. doi:10.5005/ijcdas-52-4-203
  22. Pleasants RA, Riley IL, Mannino DM. Defining and targeting health disparities in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease. 2016;11: 2475–2496. doi:10.2147/COPD.S79077
  23. Fabbri LM, Celli BR, Agustí A, Criner GJ, Dransfield MT, Divo M, et al. COPD and multimorbidity: recognising and addressinga syndemic occurrence. The Lancet Respiratory Medicine. 2023;11(11): 1020–1034. doi:10.1016/S2213-2600(23)00261-8
  24. Barnes PJ. Emerging concepts in COPD mechanisms: the role of small airways and silent inflammation. Respiratory Research. 2024;25(1): 56. doi: 10.1186/s12931-024-02684-7
  25. Martinez CH, Han MK. Contribution of environmental factors to COPD exacerbations. The Lancet Respiratory Medicine. 2023;11(8): 679–692. doi: 10.1016/S2213-2600(23)00207-8
  26. Agusti A, Celli BR. Personalized medicine in COPD: where are we and where do we need to go? European Respiratory Journal. 2024;63(2): 2200405. doi: 10.1183/13993003.00405-2022
DOI: https://doi.org/10.2478/pneum-2025-0015 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Language: English
Page range: 95 - 104
Published on: Jul 23, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2025 Anil Sontakke, Preetam Dhande, Rajasi Bundale, Saood Ali, Harshal Ital, Hrishikesh Gaikwad, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.